Compound Name (alphabetical) | Binding Targets | Enz. Inhib. Data | ITC Data | Alternate Compound Names |
---|
Ki | IC50 | Kd | EC50 | Koff | Kon | Other |
---|
BDBM100259
| - ADAM17
- Alpha trans-inducing protein (VP16)
- COUP transcription factor 2 isoform a
- Disintegrin and metalloproteinase domain-containing protein 10 (ADAM10)
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - 2-hydroxy-3-[(E)-3-(4-nitrophenyl)-1-oxoprop-2-enyl]-1-cyclohepta-2,4,6-trienone
- 2-hydroxy-3-[(E)-3-(4-nitrophenyl)acryloyl]cyclohepta-2,4,6-trien-1-one
- 2-hydroxy-3-[(E)-3-(4-nitrophenyl)prop-2-enoyl]cyclohepta-2,4,6-trien-1-one
- 3-[(E)-3-(4-nitrophenyl)prop-2-enoyl]-2-oxidanyl-cyclohepta-2,4,6-trien-1-one
- MLS002701851
- SMR001565443
- cid_6302331
|
BDBM100348
| - Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
- Tyrosine-protein kinase SYK
| 0 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | - US8501944, 370
- US8501944, 374
|
BDBM100350
| - Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
- Tyrosine-protein kinase SYK
| 0 | 8 | 12 | 0 | 0 | 0 | 0 | 0 | - US8501944, 372
- US8501944, 375
|
BDBM100351
| - Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
- Tyrosine-protein kinase SYK
| 0 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | - US8501944, 373
- US8501944, 376
|
BDBM10145
| - Beta-secretase 1
- Beta-secretase 2
- Cathepsin D
- HIV-1 Protease
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - lysine sulfonamide analogue 9
- methyl N-[(1S)-1-{[(5R)-5-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-6-hydroxyhexyl]carbamoyl}-2-phenylethyl]-N-methylcarbamate
- sulfonamide tricyclic analogue, 9
|
BDBM10246
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 3 | 22 | 0 | 0 | 0 | 0 | 0 | 1 | - (4S)-4-{[(1S)-1-{[(2S)-1-carboxy-3-oxopropan-2-yl]carbamoyl}-2-methylpropyl]carbamoyl}-4-[(3S)-3-acetamido-3-formamidopropanoic acid]butanoic acid
- Ac-DEVD-CHO
- CHEMBL417149
|
BDBM103736
| - JAK1 (aa850-1154)
- JAK2 (aa 808-1132)
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - US10206907, Compound 207
- US8563545, 10
|
BDBM103908
| - Carbonic anhydrase 2
- Carbonic anhydrase 9
- JNK3
- c-Jun N-terminal kinase, JNK
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - JNK3 inhibitor 5
- US8562945, 241
|
BDBM103909
| - Carbonic anhydrase 2
- Carbonic anhydrase 9
- JNK3
- c-Jun N-terminal kinase, JNK
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - JNK3 inhibitor 6
- US8562945, 242
|
BDBM103910
| - Carbonic anhydrase 2
- Carbonic anhydrase 9
- JNK3
- c-Jun N-terminal kinase, JNK
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - JNK3 inhibitor 7
- US8562945, 243
|
BDBM104066
| - Death-associated protein kinase 1
- Serine/threonine-protein kinase PIM
- Serine/threonine-protein kinase pim-2
- Serine/threonine-protein kinase pim-3
| 0 | 0 | 6 | 0 | 0 | 0 | 0 | 0 | |
BDBM104101
| - HIV-1 protease
- HIV-1 protease M2
- HIV-1 protease M3
- HIV-1 protease M4
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM104110
| - HIV-1 protease M1
- HIV-1 protease M2
- HIV-1 protease M3
- HIV-1 protease M4
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 3-Hydroxy-N-[(1S,2R)-2-hydroxy-3-[[[5-(5-isoxazolyl)-2-thienyl]sulfonyl](2- methylbutyl)amino]-1-(phenylmethyl)propyl]-benzamide (AF-80)
|
BDBM104689
| - Orexin receptor type 1
- Orexin receptor type 1 (OX1)
- Orexin receptor type 2
- Orexin receptor type 2 (OX2)
| 4 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM104692
| - Orexin receptor type 1
- Orexin receptor type 1 (OX1)
- Orexin receptor type 2
- Orexin receptor type 2 (OX2)
| 10 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM104963
| - Dual specificity mitogen-activated protein kinase kinase 1
- Mitogen-activated protein kinase 1
- Mitogen-activated protein kinase kinase kinase 8
- RAF serine/threonine protein kinase
| 0 | 10 | 2 | 0 | 0 | 0 | 0 | 0 | |
BDBM10527
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-bromo-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid
- BROMOMETHOXYPHENYL INHIBITOR
- valine aspartyl ketone 29
- valine aspartyl ketone 6
- valine aspartyl ketone analog 10
|
BDBM10528
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)propanamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 7
|
BDBM10529
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pentanamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 8
|
BDBM10530
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-phenylpropanamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 9
|
BDBM10531
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 10
|
BDBM10532
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-{[1-(5-bromo-2-methoxyphenyl)cyclopropyl]formamido}-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 11
|
BDBM10533
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-enamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 12
|
BDBM10534
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 13
|
BDBM10535
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-(5-bromo-2-methoxyphenyl)pent-4-ynamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 14
|
BDBM10536
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-(1-phenylacetamido)butanamido]-4-oxopentanoic acid
- valine aspartyl ketone 15
- valine aspartyl ketone analog 9
|
BDBM10537
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 16
|
BDBM10538
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 17
|
BDBM10539
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2R)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 18
|
BDBM10540
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-hydroxy-3-methylbutanamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 19
|
BDBM10541
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(2S)-2-methoxy-2-phenylacetamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 20
|
BDBM10542
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-phenylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 21
|
BDBM10543
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2,2-diphenylacetamido)-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 22
|
BDBM10544
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-ethyl-2-hydroxybutanamido)-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 23
|
BDBM10545
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-(2-hydroxy-2-methylpropanamido)-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 24
|
BDBM10546
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[(1-hydroxycyclopropyl)formamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 25
|
BDBM10547
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-3-methyl-2-[3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propanamido]butanamido]-4-oxopentanoic acid
- valine aspartyl ketone 26
|
BDBM10548
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(2,5-dimethoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 27
- valine aspartyl ketone analog 1
|
BDBM10549
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(2,5-dimethoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 28
|
BDBM10551
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[2-(5-bromo-2-methoxyphenyl)-2-hydroxyacetamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 30
|
BDBM10552
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-acetyl-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid
- valine aspartyl ketone 31
- valine aspartyl ketone analog 15
|
BDBM10553
| - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| 0 | 4 | 0 | 0 | 0 |